• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于药物递送的天然纳米颗粒:负载阿霉素的鳄梨外泌体的蛋白质组学见解及抗癌潜力

Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.

作者信息

Salem Dina, Abdel-Ghany Shaimaa, Mohamed Eman, Alahmady Nada F, Alqosaibi Amany, Al-Dhuayan Ibtesam S, Alnamshan Mashal Meshal, Arneth Rebekka, Arneth Borros, Sabit Hussein

机构信息

Department of Agriculture Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza 12566, Egypt.

Department of Environmental Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza 12566, Egypt.

出版信息

Pharmaceuticals (Basel). 2025 Jun 4;18(6):844. doi: 10.3390/ph18060844.

DOI:10.3390/ph18060844
PMID:40573239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12195682/
Abstract

: Exosomes have recently attracted significant attention for their potential in drug delivery. Plant-derived exosomes, in particular, may serve as direct anticancer agents due to their unique characteristics, including immunogenicity, biocompatibility, safety, cell-free nature, and nanoscale structure. : This study characterizes (avocado)-derived exosomes, exploring their anticancer properties, proteomic profile, and therapeutic potential. : Isolated exosomes exhibited a diameter of 99.58 ± 5.09 nm (non-loaded) and 151.2 ± 6.36 nm (doxorubicin (DOX)-loaded), with zeta potentials of -17 mV and -28 mV, respectively. Proteomic analysis identified 47 proteins, including conserved exosome markers (GAPDH, tubulin) and stress-response proteins (defensin, endochitinase). Functional enrichment revealed roles in photosynthesis, glycolysis, ATP synthesis, and transmembrane transport, supported by protein-protein interaction networks highlighting energy metabolism and cellular trafficking. DOX encapsulation efficiency was 18%, with sustained release (44.4% at 24 h). In vitro assays demonstrated reduced viability in breast cancer (MCF-7, T47D, 4T1) and endothelial (C166) cells, enhanced synergistically by DOX (Av+DOX). Gene expression analysis revealed cell-specific modulation: Av+DOX upregulated and in T47D but suppressed both in 4T1/C166, suggesting context-dependent mechanisms. : These findings underscore avocado exosomes as promising nanovehicles for drug delivery, combining biocompatibility, metabolic functionality, and tunable cytotoxicity. Their plant-derived origin offers a scalable, low-cost alternative to mammalian exosomes, with potential applications in oncology and targeted therapy. Further optimization of loading efficiency and in vivo validation are warranted to advance translational prospects.

摘要

外泌体因其在药物递送方面的潜力最近受到了广泛关注。特别是植物来源的外泌体,由于其独特的特性,包括免疫原性、生物相容性、安全性、无细胞性质和纳米级结构,可能作为直接的抗癌剂。本研究对鳄梨来源的外泌体进行了表征,探索其抗癌特性、蛋白质组学特征和治疗潜力。分离出的外泌体直径在未负载时为99.58±5.09nm,负载阿霉素(DOX)时为151.2±6.36nm,ζ电位分别为-17mV和-28mV。蛋白质组学分析鉴定出47种蛋白质,包括保守的外泌体标志物(甘油醛-3-磷酸脱氢酶、微管蛋白)和应激反应蛋白(防御素、内切几丁质酶)。功能富集分析显示其在光合作用、糖酵解、ATP合成和跨膜运输中发挥作用,蛋白质-蛋白质相互作用网络突出了能量代谢和细胞运输。DOX包封效率为18%,具有持续释放特性(24小时时释放44.4%)。体外试验表明,其可降低乳腺癌(MCF-7、T47D、4T1)和内皮细胞(C166)的活力,DOX(Av+DOX)可增强这种作用。基因表达分析揭示了细胞特异性调节:Av+DOX在T47D中上调了和,但在4T1/C166中均下调,表明存在背景依赖性机制。这些发现强调了鳄梨外泌体作为有前景的药物递送纳米载体的潜力,其兼具生物相容性、代谢功能和可调节的细胞毒性。其植物来源为哺乳动物外泌体提供了一种可扩展、低成本的替代方案,在肿瘤学和靶向治疗中具有潜在应用。有必要进一步优化负载效率并进行体内验证,以推进转化前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/dc5f70aa9db5/pharmaceuticals-18-00844-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/26f8486240f9/pharmaceuticals-18-00844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/a02e508246a0/pharmaceuticals-18-00844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/5077b1da1efd/pharmaceuticals-18-00844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/487046cf1ca6/pharmaceuticals-18-00844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/cc06ec694b6a/pharmaceuticals-18-00844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/ac5ffb9c18cb/pharmaceuticals-18-00844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/225a97022d7a/pharmaceuticals-18-00844-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/c8bc9b89f628/pharmaceuticals-18-00844-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/a9e5191e099c/pharmaceuticals-18-00844-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/de4b43c709f2/pharmaceuticals-18-00844-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/d8c5873e07f5/pharmaceuticals-18-00844-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/dc5f70aa9db5/pharmaceuticals-18-00844-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/26f8486240f9/pharmaceuticals-18-00844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/a02e508246a0/pharmaceuticals-18-00844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/5077b1da1efd/pharmaceuticals-18-00844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/487046cf1ca6/pharmaceuticals-18-00844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/cc06ec694b6a/pharmaceuticals-18-00844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/ac5ffb9c18cb/pharmaceuticals-18-00844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/225a97022d7a/pharmaceuticals-18-00844-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/c8bc9b89f628/pharmaceuticals-18-00844-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/a9e5191e099c/pharmaceuticals-18-00844-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/de4b43c709f2/pharmaceuticals-18-00844-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/d8c5873e07f5/pharmaceuticals-18-00844-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12195682/dc5f70aa9db5/pharmaceuticals-18-00844-g012.jpg

相似文献

1
Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.用于药物递送的天然纳米颗粒:负载阿霉素的鳄梨外泌体的蛋白质组学见解及抗癌潜力
Pharmaceuticals (Basel). 2025 Jun 4;18(6):844. doi: 10.3390/ph18060844.
2
Poly(d,l-lactide--glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells.包裹阿霉素的聚(d,l-丙交酯-乙交酯)纳米颗粒用于改善胆管癌及耐药细胞的治疗
ACS Appl Bio Mater. 2025 Jun 18. doi: 10.1021/acsabm.5c00628.
3
The Synergistic and Anticancer Potential of Withania Somnifera (Ashwagandha) Ethanol Extract as an Adjuvant with Doxorubicin in MCF7 Breast Cancer Cell Line.印度人参(醉茄)乙醇提取物与阿霉素联合作为MCF7乳腺癌细胞系佐剂的协同作用及抗癌潜力
Asian Pac J Cancer Prev. 2025 Mar 1;26(3):757-766. doi: 10.31557/APJCP.2025.26.3.757.
4
Magnesium-Free Assembly of Cationic Peptide/DNA Nanostructures with Defined Geometries for Anticancer Drug Delivery.用于抗癌药物递送的具有特定几何结构的阳离子肽/DNA纳米结构的无镁组装
ACS Appl Mater Interfaces. 2025 Jul 9;17(27):38971-38984. doi: 10.1021/acsami.5c07816. Epub 2025 Jun 25.
5
Multi-Focused Acoustic Radiation Force Impulse Modulation of Murine Hepatic Xenografts Enhances Nanoscale DOX@Lip Delivery and Therapeutic Effect.小鼠肝异种移植瘤的多聚焦声辐射力脉冲调制增强纳米级阿霉素脂质体递送及治疗效果
Int J Nanomedicine. 2025 Jun 12;20:7359-7373. doi: 10.2147/IJN.S522247. eCollection 2025.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Harnessing Mammalian- and Plant-Derived Exosomes for Drug Delivery: A Comparative Review.利用哺乳动物和植物来源的外泌体进行药物递送:比较综述。
Int J Mol Sci. 2025 May 19;26(10):4857. doi: 10.3390/ijms26104857.
8
Mineralized osteoblast-derived exosomes and 3D-printed ceramic-based scaffolds for enhanced bone healing: A preclinical exploration.矿化成骨细胞衍生外泌体与3D打印陶瓷基支架促进骨愈合:一项临床前探索
Acta Biomater. 2025 Jun 15;200:686-702. doi: 10.1016/j.actbio.2025.05.051. Epub 2025 May 21.
9
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer.关于阿霉素的全面综述:乳腺癌中的作用机制、毒性、临床试验、联合疗法及纳米制剂
Drug Deliv Transl Res. 2025 Jan;15(1):102-133. doi: 10.1007/s13346-024-01648-0. Epub 2024 Jun 17.
2
Exosomes: Mediators of cellular communication in potentially malignant oral lesions and head and neck cancers.外泌体:潜在恶性口腔病变和头颈部癌症中细胞通讯的介导者。
F1000Res. 2023 Oct 4;12:58. doi: 10.12688/f1000research.127368.2. eCollection 2023.
3
Development of Blueberry-Derived Extracellular Nanovesicles for Immunomodulatory Therapy.
用于免疫调节治疗的蓝莓源细胞外纳米囊泡的研发
Pharmaceutics. 2023 Aug 10;15(8):2115. doi: 10.3390/pharmaceutics15082115.
4
Critical Role of the cGAS-STING Pathway in Doxorubicin-Induced Cardiotoxicity.cGAS-STING 通路在多柔比星诱导的心脏毒性中的关键作用。
Circ Res. 2023 May 26;132(11):e223-e242. doi: 10.1161/CIRCRESAHA.122.321587. Epub 2023 May 8.
5
Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis.载利福平的载有 Angiopep-2 修饰的外泌体具有治疗中枢神经系统结核的潜力。
Int J Nanomedicine. 2023 Jan 27;18:489-503. doi: 10.2147/IJN.S395246. eCollection 2023.
6
Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.基于外泌体的智能药物递送工具用于癌症治疗诊断。
ACS Biomater Sci Eng. 2023 Feb 13;9(2):577-594. doi: 10.1021/acsbiomaterials.2c01329. Epub 2023 Jan 9.
7
Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.用于治疗应用的杂交外泌体、类外泌体纳米囊泡和工程化外泌体。
J Control Release. 2023 Jan;353:1127-1149. doi: 10.1016/j.jconrel.2022.12.027. Epub 2022 Dec 26.
8
Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications.植物来源的细胞外囊泡:在生物医学应用中使用它们的最新进展和当前挑战。
J Extracell Vesicles. 2022 Dec;11(12):e12283. doi: 10.1002/jev2.12283.
9
Drug Value of Drynariae Rhizoma Root-Derived Extracellular Vesicles for Neurodegenerative Diseases Based on Proteomics and Bioinformatics.基于蛋白质组学和生物信息学的中药骨碎补来源细胞外囊泡治疗神经退行性疾病的药物价值。
Plant Signal Behav. 2022 Dec 31;17(1):2129290. doi: 10.1080/15592324.2022.2129290.
10
Do Extracellular Vesicles Derived from Mesenchymal Stem Cells Contain Functional Mitochondria?间充质干细胞来源的细胞外囊泡是否含有功能性线粒体?
Int J Mol Sci. 2022 Jul 3;23(13):7408. doi: 10.3390/ijms23137408.